Pharmaceuticals
Theranos may lose licence; top execs face ban
14 Apr 2016
Pfizer calls halt to $160bn merger with Allergan: report
06 Apr 2016
The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months
New Treasury rules threaten Allergan-Pfizer merger
05 Apr 2016
The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm
NPPA brings down prices of 103 drug formulations
02 Apr 2016
